Ignite Creation Date:
2024-05-05 @ 11:55 AM
Last Modification Date:
2024-10-26 @ 9:16 AM
Study NCT ID:
NCT00175656
Status:
COMPLETED
Last Update Posted:
2011-04-14
First Post:
2005-09-13
Brief Title:
Titanium Elastic Nails in the Treatment of Pediatric Femur Fractures
Sponsor:
University of British Columbia
Organization:
University of British Columbia
Study Overview
Official Title:
Titanium Elastic Nails in the Treatment of Paediatric Femoral Fractures A Prospective Randomized Clinical Trial of Eliminating Nail Protrusion to Decrease Soft Tissue Complications
Status:
COMPLETED
Status Verified Date:
2011-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Titanium elastic nails in the pediatric femoral fractures A prospective randomized clinical trial of eliminating nail protrusion to decrease soft tissue complications
Detailed Description:
This study will be conducted as a prospective cohort study of children and adolescents treated with TEN for a femoral shaft fracture All children and adolescents presenting to the Emergency department of a participating center with a femur fracture will be approached for inclusion in the study The primary outcome for this study will be functional recovery as measured using a pediatric specific generic QOL measurement tool The clinical outcome measure which will be used will be the performance version of the ASK ASK-p which has been previously tested and shown to be valid reliable and responsive in children and adolescents with acute and chronic Orthopaedic disorders The first time point for data collection will be at four months Clinical data which will be obtained over the course of follow-up will include clinical evaluation of hip and knee range of motion limb rotation clinical measurement of limb length fracture union and the presence of complications including the need for nail removal in the group in which it was not planned The second time point for data collection will be at one year Again the ASK-p will be mailed to all subjects in advance to allow completion at the desired time The return of questionnaires and process for reminder notifications will proceed in a similar fashion to the four month time point Clinical and radiographic data will be collected in a similar fashion to the four month time point No subjects will be excluded on the basis of failure to return questionnaires at the one year time point since this represents a secondary outcome
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| W03-0165 | None | None | None |